Europe needs genetically engineered crops, scientists say
2013-04-25
(Press-News.org) The European Union cannot meet its goals in agricultural policy without embracing genetically engineered crops (GMOs). That's the conclusion of scientists who write in Trends in Plant Science, a Cell Press publication, based on case studies showing that the EU is undermining its own competitiveness in the agricultural sector to its own detriment and that of its humanitarian activities in the developing world.
"Failing such a change, ultimately the EU will become almost entirely dependent on the outside world for food and feed and scientific progress, ironically because the outside world has embraced the technology which is so unpopular in Europe, realizing this is the only way to achieve sustainable agriculture," said Paul Christou of the University of Lleida-Agrotecnio Center and Institució Catalana de Recerca i Estudis Avançats in Spain.
"Many aspects of the EU agricultural policy, including those concerning GMOs, are internally inconsistent and actively obstruct what the policy sets out to achieve," Christou and his colleagues continued.
For instance, the Lisbon Strategy aims to create a knowledge-based bioeconomy and recognizes the potential of GMOs to deliver it, but EU policy on the cultivation of GMOs has created an environment that makes this impossible. In reality, there is a de facto moratorium in Europe on the cultivation of genetically engineered crops such as maize, cotton, and soybean, even as the same products are imported because there is insufficient capacity to produce them by conventional means at home.
Subsidies designed to support farmers now benefit large producers at the expense of family farms, Christou says. The EU has also banned its farmers from using many pesticides and restricted them from other nonchemical methods of pest control, while allowing food products produced in the same ways to be imported.
"EU farmers are denied freedom of choice—in essence, they are prevented from competing because EU policies actively discriminate against those wishing to cultivate genetically engineered crops, yet exactly the same crops are approved for import," Christou says.
All this, he says, despite the fact that GMOs must pass stringent safety tests and there has been no evidence of harm or health risks, despite more than 15 years of GMO agriculture around the world.
"We recommend the adoption of rational, science-based principles for the harmonization of agricultural policies to prevent economic decline and lower standards of living across the continent," the authors write. And that means short-term political expediency mustn't trump long-term objectives on challenges, including hunger and malnutrition.
###
Trends in Plant Science, Masip et al.: "Paradoxical EU agricultural policies on genetically engineered crops."
END
ELSE PRESS RELEASES FROM THIS DATE:
2013-04-25
In many places around the world, people are living longer and are having fewer children. But that's not all. A study of people living in rural Gambia, published in the Cell Press journal Current Biology on April 25, shows that this modern-day "demographic transition" may lead women to be taller and slimmer, too.
"This is a reminder that declines in mortality rates do not necessarily mean that evolution stops, but that it changes," says Ian Rickard of Durham University in the United Kingdom.
Rickard and Alexandre Courtiol of the Leibniz Institute for Zoo and Wildlife ...
2013-04-25
Alzheimer's disease is the most common neurodegenerative disorder, affecting more than five million Americans, but currently there is no way to prevent, delay or stop its progression. A study published online April 25 by the Cell Press journal Neuron shows that a gene called CD33 contributes to Alzheimer's disease by inhibiting the ability of immune cells to remove toxic molecules in the brain. The findings provide new insights into the molecular causes of the disease and reveal a novel potential therapy that could prevent cognitive decline and brain damage at early stages.
"Before ...
2013-04-25
Most information about the cause of Alzheimer's disease is based on studies from animal models. Now, a study published by Cell Press on April 25th in the journal Cell examines the brain tissue of deceased human patients and sheds light on dysfunctions in molecular networks in the brain that are at the root of Alzheimer's disease. By showing that the TYROBP gene plays a key role in disrupting immune system pathways in the brains of Alzheimer's patients, the study reveals a potential therapeutic target for preventing brain damage caused by this debilitating disease.
"Our ...
2013-04-25
Cambridge, MA, April 25, 2013 --- Researchers at the Harvard Stem Cell Institute (HSCI) have discovered a hormone that holds promise for a dramatically more effective treatment of type 2 diabetes, a metabolic illness afflicting an estimated 26 million Americans. The researchers believe that the hormone might also have a role in treating type 1, or juvenile, diabetes.
The work was published today by the journal Cell as an early on-line release. It is scheduled for the May 9 print edition of the journal.
The hormone, called betatrophin, causes mice to produce insulin-secreting ...
2013-04-25
Scientists from the Icahn School of Medicine at Mount Sinai, in collaboration with researchers from Icelandic Heart Association, Sage Bionetworks, and other institutions, have discovered that a network of genes involved in the inflammatory response in the brain is a crucial mechanism driving Late Onset Alzheimer’s Disease (LOAD). The findings, published online today in the journal Cell, provide new understanding of key pathways and genes involved in LOAD and valuable insights to develop potential therapies for the disease.
To date, scientists have been challenged in ...
2013-04-25
When galaxies form new stars, they sometimes do so in frantic episodes of activity known as starbursts. These events were commonplace in the early Universe, but are rarer in nearby galaxies.
During these bursts, hundreds of millions of stars are born, and their combined effect can drive a powerful wind that travels out of the galaxy. These winds were known to affect their host galaxy -- but this new research now shows that they have a significantly greater effect than previously thought.
An international team of astronomers observed 20 nearby galaxies, some of which ...
2013-04-25
Massachusetts General Hospital (MGH) investigators have determined that one of the recently identified genes contributing to the risk of late-onset Alzheimer's disease regulates the clearance of the toxic amyloid beta (A-beta) protein that accumulates in the brains of patients with the disease. In their report receiving advance online publication in Neuron, the researchers describe a protective variant of the CD33 gene that promotes clearance of A-beta from the brain. They also show that reducing expression of CD33 in immune cells called microglia enhances their ability ...
2013-04-25
Scientists funded by the National Institutes of Health have discovered a potential strategy for developing treatments to stem the disease process in Alzheimer's disease. It's based on unclogging removal of toxic debris that accumulates in patients' brains, by blocking activity of a little-known regulator protein called CD33.
"Too much CD33 activity appears to promote late-onset Alzheimer's by preventing support cells from clearing out toxic plaques, key risk factors for the disease," explained Rudolph Tanzi, Ph.D., of Massachusetts General Hospital and Harvard University, ...
2013-04-25
Cancer is typically thought to develop after genes gradually mutate over time, finally overwhelming the ability of a cell to control growth. But a new closer look at genomes in prostate cancer by an international team of researchers reveals that, in fact, genetic mutations occur in abrupt, periodic bursts, causing complex, large scale reshuffling of DNA driving the development of prostate cancer.
In the April 25 issue of Cell, the scientists, led by researchers from Weill Cornell Medical College, the Broad Institute, Dana-Farber Cancer Institute and the University of ...
2013-04-25
A collaboration of plant and soil scientists from across the UK has shown a grass hybrid species could help reduce the impact of flooding.
The BBSRC-funded scientists, from Rothamsted Research, the James Hutton Institute, Institute of Biological, Environmental and Rural Sciences (IBERS) at Aberystwyth University, Lancaster University and the University of Nottingham, used a hybridised species of grass called perennial ryegrass (Lolium perenne) with a closely related species called meadow fescue (Festuca pratensis).
They hoped to integrate the rapid establishment ...
LAST 30 PRESS RELEASES:
[Press-News.org] Europe needs genetically engineered crops, scientists say